Glucocorticoid/NN
resistance/NN
in/IN
chronic/JJ
asthma/NN
./.
=====
Glucocorticoid/NN
pharmacokinetics/NNS
,/,
glucocorticoid/NN
receptor/NN
characteristics/NNS
,/,
and/CC
inhibition/NN
of/IN
peripheral/JJ
blood/NN
T/NN
cell/NN
proliferation/NN
by/IN
glucocorticoids/NNS
in/FW
vitro/FW
./.

A/DT
total/NN
of/IN
37/CD
chronic/JJ
,/,
severe/JJ
,/,
nonsmoking/JJ
asthmatic/JJ
patients/NNS
with/IN
documented/JJ|VBN
reversible/JJ
airways/NNS
obstruction/NN
were/VBD
classified/VBN
as/IN
glucocorticoid-sensitive/JJ
or/CC
-resistant/JJ
on/IN
the/DT
basis/NN
of/IN
changes/NNS
in/IN
FEV1/NN
,/,
FVC/NN
,/,
and/CC
peak/JJ
expiratory/NN
flow/NN
(/(
PEF/NN
)/)
after/IN
oral/JJ
prednisolone/NN
./.
=====
The/DT
resistant/JJ
patients/NNS
showed/VBD
no/DT
significant/JJ
improvements/NNS
in/IN
airflow/NN
limitation/NN
./.
=====
Phytohemagglutinin/NN
(/(
PHA/NN
)/)
-induced/JJ
proliferation/NN
of/IN
peripheral/JJ
blood/NN
T/NN
lymphocytes/NNS
from/IN
the/DT
sensitive/JJ
but/CC
not/RB
the/DT
resistant/JJ
asthmatic/JJ
patients/NNS
was/VBD
significantly/RB
(/(
p/NN
less/JJR
than/IN
0.01/CD
)/)
inhibited/VBN
by/IN
dexamethasone/NN
(/(
10/CD
(/(
-7/CD
)/)
mol/L/NN
)/)
,/,
reflecting/VBG
a/DT
shift/NN
of/IN
the/DT
dose-response/JJ
curve/NN
./.
=====
When/WRB
all/PDT
the/DT
asthmatic/JJ
patients/NNS
were/VBD
analyzed/VBN
together/RB
,/,
there/EX
was/VBD
a/DT
significant/JJ
correlation/NN
between/IN
the/DT
degree/NN
of/IN
sensitivity/NN
of/IN
T/NN
cells/NNS
to/TO
dexamethasone/NN
and/CC
the/DT
clinical/JJ
responsiveness/NN
to/TO
prednisolone/JJ
(/(
p/NN
less/RBR
than/IN
0.01/CD
)/)
./.
=====
No/DT
differences/NNS
were/VBD
observed/VBN
between/IN
six/CD
of/IN
the/DT
sensitive/JJ
and/CC
resistant/JJ
patients/NNS
in/IN
the/DT
clearance/NN
of/IN
plasma/NN
prednisolone/JJ
derived/VBN
from/IN
orally/RB
administered/VBN
prednisone/NN
./.
=====
Peripheral/JJ
blood/NN
mononuclear/JJ
cell/NN
glucocorticoid/NN
receptors/NNS
were/VBD
also/RB
characterized/VBN
in/IN
five/CD
sensitive/JJ
and/CC
seven/CD
resistant/JJ
patients/NNS
./.
=====
The/DT
numbers/NNS
and/CC
binding/NN
affinities/NNS
of/IN
these/DT
receptors/NNS
could/MD
not/RB
account/VB
for/IN
the/DT
observed/VBN
difference/NN
in/IN
the/DT
susceptibility/NN
of/IN
these/DT
cells/NNS
to/TO
functional/JJ
inhibition/NN
by/IN
dexamethasone/NN
in/FW
vitro/FW
./.
=====
These/DT
results/NNS
suggest/VBP
that/IN
clinical/JJ
glucocorticoid/NN
resistance/NN
in/IN
chronic/JJ
asthma/NN
does/VBZ
not/RB
reflect/VB
abnormal/JJ
glucocorticoid/NN
clearance/NN
but/CC
may/MD
be/VB
due/JJ
at/IN
least/JJS
partly/RB
to/TO
a/DT
relative/JJ
insensitivity/NN
of/IN
T/NN
lymphocytes/NNS
to/TO
glucocorticoids/NNS
./.
=====
This/DT
lack/NN
of/IN
sensitivity/NN
is/VBZ
unexplained/JJ
but/CC
is/VBZ
not/RB
attributable/JJ
to/TO
abnormalities/NNS
of/IN
cellular/JJ
glucocorticoid/NN
receptors/NNS
./.